GGrantIndex
Sort

40,608 grants matching prostate cancer

Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods

$1,185,393
Daniel B Vigneron · University Of California, San Francisco · R01 · FY2016 · EB

CNTR OF EXCELLENCE FOR PROSTATE CANCER RESEARCH EDUCATION AND COMM SERVICE

$1,185,214
Shafiq A Khan · Clark Atlanta University · P20 · FY2012 · MD

Anti-carcinogenic Activity Of Cox inhibitors and NAG-1

$1,185,009
Thomas Eling · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES

National Cooperative Drug Discovery Groups for Cancer

$1,184,968
University Of California Santa Cruz · U19 · FY2005 · CA

Overhauser Enhanced Magnetic Resonance Imaging (OMRI)

$1,183,002
Murali Krishna · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

PROSTATE CANCER: TRANSITION TO ANDROGEN-INDEPENDENCE

$1,182,577
University Of North Carolina Chapel Hill · P01 · FY2002 · CA

PLCO Trial Etiologic and Early Marker Study

$1,182,573
Steven Moore · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA

IMAGING PROSTATE CANCER MICROENVIRONMENT BY COLLAGEN HYBIRDIZATION

$1,182,526
The Johns Hopkins University · · FY2012 · Department of the Army

Enhancing Native American Participation in RT Trials

$1,182,097
Daniel G Petereit · Rapid City Regional Hospital · U56 · FY2006 · CA

PSMA-TARGETED IN SITU IMMUNIZATION FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

$1,182,038
University Of Wisconsin System · · FY2022 · Defense Health Agency

Molecular Basis for the Pathogenesis of Murine Retroviruses

$1,181,952
Sandra K Ruscetti · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

A first in human clinical study of TT101, a synthetic immunomodulatory material to build new functional tissue over exposed bone as a one time treatment for diabetic limb preservation patients

$1,181,406
Stephanie Deshayes · Tempo Therapeutics, Inc. · R44 · FY2022 · DK

Novel Small-Molecule Inhibitors of Bcl-2/Bcl-xL Protein*

$1,181,076
Shaomeng Wang · University Of Michigan At Ann Arbor · U19 · FY2008 · CA

VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program

$1,180,709
Khalid Matin · Virginia Commonwealth University · UG1 · FY2022 · CA

Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods

$1,180,441
Daniel B Vigneron · University Of California, San Francisco · U01 · FY2021 · EB

Molecular and Functional Characterization of Colon Tumor Cancer Stem Cells and St

$1,180,000
Michael Clarke · Stanford University · U54 · FY2006 · CA

General Studies of Epidemiology

$1,179,864
Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA

THERAPEUTIC TARGETING OF B7-H3 TO REVERSE PROSTATE CANCER TREATMENT RESISTANCE

$1,179,792
Duke University · · FY2016 · Department of the Army

68GA BOMBESIN PET/MRI IN PATIENTS WITH BIOCHEMICALLY RECURRENT PROSTATE CANCER AND NONCONTRIBUTORY CONVENTIONAL IMAGING

$1,179,426
The Leland Stanford Junior University · · FY2016 · Department of the Army

Novel Molecular Therapies of Prostate Cancer

$1,179,015
Dario C. Altieri · Wistar Institute · P01 · FY2019 · CA

Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer

$1,178,938
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research

$1,178,714
Catherine M. Tangen · Fred Hutchinson Cancer Research Center · U01 · FY2020 · CA

Cell and Cancer Biology Branch Confocal Microscopy Core

$1,178,054
Yvona Ward · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA

1/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

$1,178,009
Brian M. Rivers · Morehouse School Of Medicine · U54 · FY2021 · CA

Aspirin/Folate Prevention of Large Bowel Polyps

$1,177,669
John Anthony Baron · Univ Of North Carolina Chapel Hill · R01 · FY2010 · CA